PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer.

Xijia Zhou, Yingshu Cao, Ranwei Li, Xin Di, Yanqiao Wang, Ke Wang

Biochemical and biophysical research communications 2024 Apr 16

filter terms:

PEI is a cationic polymer, serving as a non-viral transfection carrier grounded in nanotechnology that enhances transfection efficiency via the proton sponge effect. RBM5 is an RNA-binding protein that can inhibit tumor development. This study involved the transfection of RBM5 in prostate cancer cells with PEI, Lipo2000, and their combination. Transwell and wound healing assays were used to observe invasion and migration of prostate cancer cells and flow cytometry was used to observe the apoptosis. Detect the expression of invasion and migration-related protein MMP9 through western blotting experiment. An activity detection kit was used to detect the activity of apoptotic protein caspase-3. We found that there was no significant difference in transfection efficiency when PEI and Lipo2000 were used alone but it significantly improved when they are combined. RBM5 reduced invasion, migration, and proliferation of prostate cancer and enhanced apoptosis. MMP9 expression was reduced, and the activity of caspase-3 was increased. PEI transfection could improve the inhibition of RBM5 on tumors more than Lipo2000. The inhibitory effect is more obvious when the two are used together. RBM5 transfected with PEI can amplify its inhibitory effect on prostate cancer, and this effect is more evident when combined with Lipo2000. Copyright © 2024 Elsevier Inc. All rights reserved.

Citation

Xijia Zhou, Yingshu Cao, Ranwei Li, Xin Di, Yanqiao Wang, Ke Wang. PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer. Biochemical and biophysical research communications. 2024 Apr 16;704:149703